Physician profile
Michelle Quintos Perez
NPI 1629366323
$2,170.25
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $81.40 · 2022: $502 · 2023: $1,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $351.00 | 2021-2023 | Valtoco |
| Ucb, INC. | $303.52 | 2022-2023 | Briviact |
| Corium, LLC | $218.61 | 2023 | Azstarys |
| Jazz Pharmaceuticals INC. | $217.09 | 2022-2023 | Epidiolex |
| Sumitomo Pharma America, INC. | $195.62 | 2023 | Aptiom |
| Ironshore Pharmaceuticals INC. | $151.66 | 2022-2023 | Jornay Pm |
| Immedica Pharma US, INC. | $121.84 | 2023 | |
| Sk Life Science, INC. | $102.15 | 2023 | |
| Aquestive Therapeutics, INC. | $90.37 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $75.90 | 2021-2023 | Qelbree |
| Biogen, INC. | $64.46 | 2022-2023 | Spinraza |
| Biocodex, INC. | $58.70 | 2023 | Diacomit |
| Livanova USA, INC. | $43.72 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Eisai INC. | $38.43 | 2022-2023 | |
| Aprecia Pharmaceuticals, LLC | $29.72 | 2022-2023 | Spritam |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $27.61 | 2023 | |
| Azurity Pharmaceuticals, INC. | $23.33 | 2023 | Eprontia |
| Ns Pharma, INC. | $16.73 | 2021 | |
| Currax Pharmaceuticals LLC | $13.56 | 2022 | |
| Tris Pharma INC | $13.12 | 2023 | Dyanavel Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.